HOPKINTON, Mass., Jan. 10 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) President and CEO, Kevin Hrusovsky, will present at the JPMorgan 26th Annual Healthcare Conference in San Francisco, California, today, Thursday, January 10, 2008 at 2:00 p.m. PST. Mr. Hrusovsky will discuss Caliper's outlook for 2008, and the company's preliminary expectations regarding top-level revenue performance for 2007.
Based on preliminary, unaudited financial data the company expects to report total revenue of approximately $39.5 million for the fourth quarter of 2007 and approximately $140 million for the full year, in each case at the top end of the company's previously announced projections. Within fourth quarter revenue of approximately $39.5 million, combined product and service revenue is expected to be approximately $37 million, an increase of 16% over fourth quarter 2006 combined product and service revenue.
A live webcast of Mr. Hrusovsky's presentation can be accessed at http://www.metameetings.com/webcasts/jpmorgan/healthcare08/. An archived presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of leading-edge
technologies enabling researchers in the life sciences industry to create
life-saving and enhancing medicines and diagnostic tests more quickly and
efficiently. Caliper is aggressively innovating new technology to bridge
the gap between in vitro assays and in vivo results and then translating
those results into cures for human disease. Caliper's portfolio of
offerings includes state-of-the-art microfluidics, lab automation & liquid
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved